The ECNP Congress is Europe's largest meeting on applied and translational neuroscience. Annually it brings together between 4，000 and 7，000 psychiatrists， neuroscientists， neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of disorders of the brain.

　　Spanning the spectrum of human mood， behaviour， cognition and emotion from basic science to clinical care the ECNP Congress is Europe's premier showcase for new research， treatments and technologies in applied brain science.

　　Featured topics in 2014 include：

　　TAAR1： from cell to clinic

　　Adult neurogenesis in anxiety and mood disorders

　　Personalised treatment of major depression

　　New European pharma research initiatives

　　Neuropeptides， obesity and addiction

　　Neurobiology of ADHD across the lifespan

　　Significant registration discounts are offered to junior scientists （below the age of 40） delegates from developing-economy countries， and those registering on before 15 April.

　　For an overview of the activities that will take place during the 27th ECNP Congress please view the congress at a glance.

　　The 27th ECNP Congress foundation is a public-interest-serving entity.

　　Who is the ECNP Congress for？

　　Medical researchers in neuropsychopharmacology， psychiatry and neurology

　　Clinicians and practitioners

　　Neuroscientists

　　Public health professionals

　　When and where is it？

　　The congress is held annually in autumn. It rotates between four fixed venues Amsterdam， Barcelona， Paris and Vienna and one variable venue.